CJC-1295/Ipamorelin
Growth Hormone SecretagogueResearch use only
Educational use only. Not medical advice. Verify all information with primary sources and a licensed clinician before use.
Body Map
MusclesSkinJoints
Overview
A dual-pathway protocol combining CJC-1295 and Ipamorelin that targets growth hormone secretion through complementary mechanisms. CJC-1295 demonstrates 2-10 fold GH increases with 6-8 day duration, while Ipamorelin provides selective GH release without cortisol elevation. Also known as: CJC/IPA Protocol (CJC-1295/Ipamorelin).
Primary Uses
Muscle Growth
Enhanced Protein Synthesis
Improved Recovery
Lean Mass Preservation
Body Composition Support
Metabolic Flexibility
Sleep Quality Enhancement
Tissue Regeneration
Accelerated Healing
Joint Health
Protocol Reference
Dose
200-300mcg of each peptide (CJC-1295 and Ipamorelin)
Frequency
Once daily, preferably in the evening
Half-life
6-8 days (CJC-1295)
Route
Subcutaneous
Evidence
Well Studied
Also in Growth Hormone Secretagogue